Executive Director, Technical Accounting COE at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

(Note: Required skills and experience section appears truncated in the provided job description and is not fully available for extraction.)

Responsibilities

Lead the Technical Accounting COE, setting the vision and strategy for technical accounting governance, policy, and compliance across all regions
Ensure consistent application of US GAAP and other relevant accounting standards globally, implementing best practices and standardized procedures
Oversee technical accounting research, issue identification, resolution, and documentation for complex transactions and emerging topics
Lead accounting treatment for acquisitions, divestitures, licensing, and partnership deals. Collaborate closely with Finance, Business Development, Legal, Tax and other relevant functions
Maintain effective internal controls and technical accounting policies to ensure the integrity of financial transactions and reporting
Contribute to technical analysis of SEC filing disclosures (including Forms 10-K, 10-Q and 8-K), ensuring accuracy, completeness, and compliance with all relevant accounting standards and regulatory requirements; collaborate with cross-functional teams to address complex disclosure issues and support transparent financial reporting
Coordinate and manage relationships with external auditors and regulatory bodies regarding technical accounting matters
Support the VP & Chief Accountant in preparing materials for the Audit Committee and Board of Directors, including technical accounting updates and risk assessments
Lead, manage, and mentor technical accounting professionals, fostering a collaborative, high-performance, and learning-focused culture
Drive continuous improvement initiatives in technical accounting processes, systems, and reporting to enhance efficiency, accuracy, and transparency
Align with key stakeholders across Finance (Controllership, FP&A, Tax, etc.) and non-Finance functions to ensure technical accounting processes support business performance
Oversee the integration and optimization of accounting systems and technologies to enhance data accuracy, timeliness, and accessibility
Attract, retain, and develop a high-performing technical accounting team globally
Establish and maintain strong relationships with senior leadership and external stakeholders
Identify opportunities for process optimization, automation, and streamlining to drive efficiency and manage risk

Skills

US GAAP

Technical Accounting

Financial Reporting

Accounting Standards

Governance

Compliance

Policy Development

Financial Transformation

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free